Apnimed director reports option reclassification, new grant
Apnimed, Inc. director Gary Sender reported several stock option movements involving Class A Common Stock and Common Stock.
Rhea-AI Filing Summary
Apnimed, Inc. director Gary Sender reported several stock option movements involving Class A Common Stock and Common Stock. On August 3, 2026, options over 51,890 shares at a $9.50 exercise price, 44,477 shares at $8.15, and 44,477 shares at $16.00 were recorded as dispositions to the issuer and corresponding acquisitions, reflecting a reclassification of Class A Common Stock into Common Stock pursuant to Rules 16b-7 and 16b-3. Separately, on July 30, 2026, Sender received a new option grant for 44,477 shares at $16.00, vesting in substantially equal monthly installments over 36 months after July 30, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
Sender Gary
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Stock Option (Right to Buy) F1, F2 | 51,890 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) F1, F2 | 51,890 | $0.00 | $0.00 |
| Disposition | Stock Option (Right to Buy) F1, F3 | 44,477 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) F1, F3 | 44,477 | $0.00 | $0.00 |
| Disposition | Stock Option (Right to Buy) F1, F4 | 44,477 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) F1, F4 | 44,477 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) F4 | 44,477 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 140,844 contracts (Direct)
Footnotes (4)
- F1. Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock.
- F2. 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after October 15, 2024, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
- F3. 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after July 7, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
- F4. The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date
Key Figures
Reclassified option shares at $9.50: 51,890 shares at $9.5000
Reclassified option shares at $8.15: 44,477 shares at $8.1500
Reclassified option shares at $16.00: 44,477 shares at $16.0000
+3 more
6 metrics
Reclassified option shares at $9.50
51,890 shares at $9.5000
Options tied to Class A to Common Stock reclassification on 2026-08-03; expiration 2034-12-12
Reclassified option shares at $8.15
44,477 shares at $8.1500
Options tied to Class A to Common Stock reclassification on 2026-08-03; expiration 2036-07-07
Reclassified option shares at $16.00
44,477 shares at $16.0000
Options tied to Class A to Common Stock reclassification on 2026-08-03; expiration 2036-07-29
New option grant shares
44,477 shares at $16.0000
Stock option grant on 2026-07-30; vests monthly over 36 months after July 30, 2026
Derivative transactions reported
7 derivative transactions
Total derivative transaction count in this Form 4
Net buy/sell shares
0 shares
netBuySellShares from transactionSummary indicating neutral net direction
Key Terms
Rule 16b-7, Rule 16b-3, reclassification, stock option, +1 more
5 terms
Rule 16b-7 regulatory
"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3"
A U.S. Securities and Exchange Commission safe-harbor rule that shields corporate insiders (officers, directors and large shareholders) from automatic short-swing profit claims when they buy or sell their company’s stock under a pre-approved, written plan that follows specific timing and nondiscretionary rules. For investors, the rule matters because it distinguishes routine, formula-driven insider transactions from opportunistic trades that could trigger automatic profit recoveries—think of it as an approved autopilot for insider trading that reduces legal uncertainty when the plan’s conditions are met.
Rule 16b-3 regulatory
"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
reclassification financial
"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3"
Reclassification is the formal change in how an asset, liability, security, transaction, or business activity is labeled on financial records or under rules. It matters to investors because the new label can alter reported profits, tax treatment, ownership rights or perceived risk—much like moving an item from 'personal' to 'business' use, it doesn't create value by itself but can change comparisons, taxes, and who controls outcomes.
stock option financial
"The shares subject to such option vest and become exercisable"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vesting financial
"25% of the shares subject to such option vest and become exercisable"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Apnimed (APMD) director Gary Sender report?
Gary Sender reported multiple stock option transactions, including paired dispositions and acquisitions tied to a reclassification of Class A Common Stock into Common Stock, plus a new grant of options for 44,477 shares on July 30, 2026.
What are the key terms of Gary Sender’s new Apnimed (APMD) option grant?
Sender received a stock option for 44,477 shares at an exercise price of $16.00 per share, expiring July 29, 2036. The option vests in substantially equal monthly installments over 36 months after July 30, 2026.
How are Gary Sender’s Apnimed (APMD) reclassified options structured?
Options over 51,890 shares at $9.50 and 44,477 shares each at $8.15 and $16.00 were shown as dispositions of Class A Common Stock options and acquisitions of Common Stock options, tied to a Rule 16b-7 and 16b-3 reclassification.
Does Apnimed (APMD) indicate a Rule 10b5-1 trading plan in this Form 4?
The document-level Rule 10b5-1 checkbox is not checked (aff_10b5_one is false), and the footnotes do not reference any Rule 10b5-1 trading plan or pre-arranged trading arrangement for these option transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
